| AD | Alzheimer’s disease |
| ALS | amyotrophic lateral sclerosis |
| BBB | blood brain barrier |
| BBG | Brilliant Blue G |
| Bz-ATP | Dibenzoyl-ATP |
| DAMPs | danger-associated molecular patterns |
| EGFP | enhanced green fluorescence protein |
| GFAP | glial fibrillary acidic protein |
| i.c.v. | intracerebroventricular |
| IL-1β | interleukin-1β |
| IR | immunoreactivity |
| KO | knockout |
| LPS | lipopolysaccharide |
| MCAO | medial cerebral artery occlusion |
| MS | multiple sclerosis |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NLRP3 | nucleotide-binding leucine-rich repeat pyrin domain containing 3 |
| NTPDases | ecto-nucleoside triphosphate diphosphohydrolases |
| OGD | oxygen-glucose deficiency |
| oxATP | oxidized ATP |
| PAMPs | pathogen-associated molecules |
| Panx-1 | pannexin-1 |
| PD | Parkinson’s disease |
| R | receptor |
| ROS | reactive oxygen species |
| SE | status epilepticus |
| SOD-1 | superoxide dismutase 1 |
| Tg | transgenic |
| TLR | toll-like receptor |
| TNF-α | tumor necrosis factor-α |
| TUNEL | terminal deoxynucleotidyl transferase dUTP nick end labeling |
| α,β-meATP | α,β-methylene ATP |